IFP Advisors Inc cut its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 38.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,678 shares of the conglomerate’s stock after selling 2,962 shares during the quarter. IFP Advisors Inc’s holdings in Danaher were worth $1,071,000 at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in the company. Capital International Investors lifted its stake in Danaher by 1.9% during the third quarter. Capital International Investors now owns 16,758,240 shares of the conglomerate’s stock worth $3,318,926,000 after purchasing an additional 312,951 shares during the last quarter. Generation Investment Management LLP lifted its stake in Danaher by 34.0% during the third quarter. Generation Investment Management LLP now owns 6,654,666 shares of the conglomerate’s stock worth $1,319,354,000 after purchasing an additional 1,689,020 shares during the last quarter. Legal & General Group Plc lifted its stake in Danaher by 5.0% during the third quarter. Legal & General Group Plc now owns 4,452,118 shares of the conglomerate’s stock worth $882,677,000 after purchasing an additional 211,053 shares during the last quarter. Fisher Asset Management LLC lifted its stake in Danaher by 0.7% in the third quarter. Fisher Asset Management LLC now owns 4,369,219 shares of the conglomerate’s stock valued at $866,241,000 after buying an additional 28,583 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its stake in Danaher by 104.7% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,333,056 shares of the conglomerate’s stock valued at $991,923,000 after buying an additional 2,216,789 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.
Danaher Price Performance
Shares of DHR opened at $172.12 on Friday. The firm has a market capitalization of $121.82 billion, a price-to-earnings ratio of 33.29, a price-to-earnings-growth ratio of 2.30 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The stock’s fifty day moving average is $183.52 and its 200-day moving average is $208.73.
Danaher Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. Danaher’s dividend payout ratio (DPR) is 30.95%.
Analyst Ratings Changes
A number of research firms have issued reports on DHR. Wells Fargo & Company cut their target price on Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 22nd. Wolfe Research cut their target price on Danaher from $260.00 to $230.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 8th. Royal Bank Of Canada began coverage on Danaher in a research note on Thursday, May 14th. They issued an “outperform” rating and a $200.00 target price on the stock. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Danaher in a research note on Thursday, January 29th. Finally, KeyCorp reiterated an “overweight” rating on shares of Danaher in a research note on Thursday, January 29th. Nineteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $238.65.
View Our Latest Stock Analysis on Danaher
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Recommended Stories
- Five stocks we like better than Danaher
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
